Shared Decision‐Making in Treatment Selection in Multiple Myeloma in Spain: The <scp>PRISMMA</scp> Study
While general agreement between patients and haematologists on extending survival with good quality of life was found for the main treatment goal, a need to align second treatment goals and improve the shared decision-making was identified. Addressing these differences is important to ensure the selection of the most appropriate treatment for the individual patient at each stage of their journey.
Authors
- Isabel López (ORCID: https://orcid.org/0009-0009-5572-1781)
- Begoña Barragán
- Valentín Cabañas (ORCID: https://orcid.org/0000-0002-6248-2549)
- María Casanova (ORCID: https://orcid.org/0000-0003-0784-7688)
- Belén Santiago‐Josefat (ORCID: https://orcid.org/0009-0009-8100-4903)
- Anna Raya
Institutions
- Hospital Costa del Sol (ES)
- Qiagen (Spain) (ES)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Spanish Ovarian Cancer Research Group (ES)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-11-09
- DOI
- https://doi.org/10.1111/ejh.70062
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen